“国医坐诊、严苛选材、精心炮制……好医好药一定是广誉远未来发展过程中所表现出来的非凡实力及信誉,也是助推复兴传统中医药魅力的关键。”近日,在“寻找晋商领袖”暨转型发展健康产业高峰论坛期间,本刊记者有幸采访到东盛集团董事长郭家学先生。作为曾名噪一时的资本狂人,如今的郭先生看上去是那样的从容与自信。谈到广誉远,郭先生毫不掩饰自豪、青睐之情。按他的话说,广誉远是健康产业中为数不多的、值得让他有信心有动力为之奋斗的“精而美”的中医药企业。未来的东盛, “State medical Zuozhen, harsh selection, carefully cooked ... good medicine and good medicine must be widely Yu Fanyuan future development demonstrated by the extraordinary strength and credibility, but also to promote the revitalization of the charm of traditional Chinese medicine key.” “Recently, In the ”looking for business leaders" and the transformation and development of health industry summit forum, the reporter was fortunate enough to interview the chairman of Dongsheng Group Mr. Guo Jiaxue. As a former capital madman, now Mr. Guo looks so calm and confident. Speaking of Yuanyuan far, Mr. Guo did not hide their pride, favor. In his words, Guangyuan is one of the few Chinese medicine companies in the health care industry that deserves his confidence and motivation to strive for. Tung Shing in the future,